English
Alembic Pharmaceuticals Q4 Results
- BSE: 533573
- NSE: APLLTD
- ISIN: INE901L01018
- Sector: Biotechnology & Drugs
BSE
845.75
-19.00 (-2.20%)
-19.00 (-2.20%)Volume4.97 K
Updated: Tue 16 Dec, 2025 | 15:29:59
NSE
847.15-17.55 (-2.03%)
-17.55 (-2.03%)Volume54.10 K
Updated: Tue 16 Dec, 2025 | 15:44:31
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Alembic Pharmaceuticals Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,566.70 | 1,502.55 | 4.27% | 1,326.40 | 18.12% |
| Depreciation/ Amortization | 68.99 | 70.04 | -1.50% | 69.48 | -0.71% |
| Operating Income | 202.93 | 190.19 | 6.70% | 190.58 | 6.48% |
| Net Income | 156.87 | 138.42 | 13.33% | 178.21 | -11.97% |
| Other Operating Expenses Total | 573.50 | 595.45 | -3.69% | 475.72 | 20.55% |
| Net Income Before Taxes | 191.94 | 177.78 | 7.96% | 182.85 | 4.97% |
| Total Revenue | 1,769.63 | 1,692.74 | 4.54% | 1,516.98 | 16.65% |
| Selling/ General/ Admin Expenses Total | 393.59 | 397.52 | -0.99% | 401.84 | -2.05% |
| Diluted Normalized EPS | 8.05 | 7.01 | 14.81% | 9.07 | -11.27% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.